Carboplatin Pfizer

Carboplatin Pfizer Use In Pregnancy & Lactation





Zuellig Pharma


Full Prescribing Info
Use In Pregnancy & Lactation
Use in Pregnancy: Category D: Carboplatin has been shown to be embryo-toxic and mutagenic, and its use in pregnant women is not recommended. Women of child-bearing potential should use adequate contraception and carboplatin should only be used in women of child-bearing potential if the expected benefits outweigh the risks of such therapy. If the patient becomes pregnant whilst receiving the drug she should be advised of the potential hazard to the foetus.
Use in Lactation: It is not known whether or not carboplatin is excreted in breast milk so breast feeding should be discontinued during carboplatin therapy in lactating women.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in